Arabic Arabic English English French French German German
dark

Tricor (fenofibrate) effective in treating severe COVID-19 patients

The SARS-CoV-2 virus has infected over 165 million people worldwide causing nearly 3.5 million deaths. Recent vaccination efforts have been hindered by multiple coronavirus variants that challenge current vaccines. While infection generally produces a mild disease, in some patients it can develop into a severe inflammatory COVID-19 requiring medical intervention. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Study identifies possible antidote for GHB overdose

Next Post

Severe COVID-19 symptoms in the elderly are consistent with a weaker immune system

Related Posts
Total
0
Share